Betzana Zambrano (Uruguay)

Sanofi Pasteur Global Clinical Development Strategy

Poster Author Of 1 e-Poster

 e-Posters
AS03.d. Vaccine efficacy (phase 3) and effectiveness – bacterial and all non-viral

PD042 - IMMUNE PERSISTENCE, IMMUNOGENICITY AND SAFETY OF A BOOSTER DOSE OF QUADRIVALENT MENINGOCOCCAL CONJUGATE VACCINE (MENACYW-TT) IN ADOLESCENTS AND ADULTS PRIMED 3 - 6 YEARS EARLIER. (ID 1111)

Session Name
0360 - Poster Discussion Session 08: Vaccine II (ID 126)
Presenter
Authors
My link to connect
https://sanofi.zoom.com/j/92118146655?pwd=eDhjYWpjU3RtTk5VLzdkZjdJR2tIQT09
Availability (Date and Time)
12th May 2022; 15:00 to 16:00 CET
e-Poster Audio MP3